Not applicableStudy completedNCT03287830What this trial is testingFlu2Text: Text Message Reminders for 2nd Dose of Influenza VaccineWho this might be right forInfluenzaVaccination Columbia University 2,105
Early research (Phase 1)Study completedNCT01335347What this trial is testingSafety Study of an Oral Vaccine to Prevent Avian InfluenzaWho this might be right forAvian InfluenzaBird Flu Vaxart 54
Post-approval studies (Phase 4)UnknownNCT05996549What this trial is testingCost-effectiveness of the Influenza VaccinationWho this might be right forInfluenza VaccineCost-EffectivenessVaccination International Centre for Diarrhoeal Disease Research, Bangladesh 2,567
Not applicableEnrolling By InvitationNCT02511002What this trial is testingLong-term Observation of Hemagglutinin and Neuraminidase Inhibition Antibody Titers After Influenza ChallengeWho this might be right forPost Influenza National Institute of Allergy and Infectious Diseases (NIAID) 200
Not applicableStudy completedNCT01146912What this trial is testingTextFluenza: Using Technology To Promote Flu Vaccination In Underserved Maternal And Child PopulationsWho this might be right forInfluenza Columbia University 30,537
Large-scale testing (Phase 3)Study completedNCT03321968What this trial is testingLot-to-lot Consistency of a Plant-Derived Quadrivalent Virus-Like Particles Influenza Vaccine in Healthy AdultsWho this might be right forVirus DiseasesRNA Virus InfectionsRespiratory Tract Infections+2 more Medicago 1,202
Not applicableStudy completedNCT01353768What this trial is testingZanamivir Aqueous Solution Compassionate Use Program Retrospective Chart Review StudyWho this might be right forInfections, Respiratory Tract GlaxoSmithKline 113
Not applicableStudy completedNCT05572450What this trial is testingDose, Safety, and Pathogenicity of a New Influenza H1N1 Challenge StrainWho this might be right forInfluenza A H1N1 Hvivo 70
Testing effectiveness (Phase 2)Study completedNCT00506350What this trial is testingEvaluate Reactogenicity & Immunogenicity of an Influenza Pandemic Candidate Vaccine (GSK1562902A) in Primed AdultsWho this might be right forInfluenza GlaxoSmithKline 350
Testing effectiveness (Phase 2)WithdrawnNCT03903718What this trial is testingEvaluation of the Safety and Efficacy of a Monoclonal Antibody to Treat InfluenzaWho this might be right forInfluenza MedImmune LLC
Testing effectiveness (Phase 2)Study completedNCT00439335What this trial is testingHigher Dose Intradermal H5 VaccineWho this might be right forInfluenza National Institute of Allergy and Infectious Diseases (NIAID) 227
Testing effectiveness (Phase 2)Study completedNCT00877448What this trial is testingA Double-Dose Safety Study of An Influenza Vaccine (Multimeric-001)Who this might be right forHealthy BiondVax Pharmaceuticals ltd. 63
Not applicableStudy completedNCT02148874What this trial is testingImmune Responses to the Flu Shot During PregnancyWho this might be right forPregnancy Lisa Christian 287
Post-approval studies (Phase 4)Study completedNCT00258817What this trial is testingPhase IV Trial to Collect Safety Data and Sera in Healthy Children Given Fluzone VaccineWho this might be right forInfluenza Sanofi Pasteur, a Sanofi Company 30
Early research (Phase 1)Active Not RecruitingNCT05945485What this trial is testingEvaluate the Safety and Immunogenicity of Two Doses of DCVC H1 HA mRNA-LNP in Healthy AdultsWho this might be right forInfluenza National Institute of Allergy and Infectious Diseases (NIAID) 50
Large-scale testing (Phase 3)Study completedNCT03704740What this trial is testingImmunogenicity and Safety of NBP607-QIV Compared to Agrippal in Children Aged 6 to 35 MonthsWho this might be right forInfluenza SK Bioscience Co., Ltd. 676
Not applicableEnded earlyNCT05105191What this trial is testingAnalytical Performances and Clinical Impact of the Roche Cobas® Liat Influenza A/B & RSV Assay in the Management of Adult and Pediatric Patients Attending the Emergency RoomWho this might be right forInfluenza Viral InfectionsRSV Infection Erasme University Hospital 280
Early research (Phase 1)Study completedNCT06125717What this trial is testingPhase 1 Evaluation of H1 Influenza Vaccine Delivered by MIMIX MAPWho this might be right forInfluenza Vaxess Technologies 45
Not applicableStudy completedNCT04678271What this trial is testingAssessment, Feedback, Incentive, Exchange (AFIX OB) A Customizable Quality Improvement Intervention to Increase Maternal Vaccine UptakeWho this might be right forInfluenzaWhooping Cough Yale University 202
Post-approval studies (Phase 4)Study completedNCT04551677What this trial is testingAnnual Study for Collection of Serum Samples in Children and Older Adults Receiving the 2020-2021 Formulations of Fluzone Quadrivalent Vaccine and Fluzone High-Dose Quadrivalent Vaccine, RespectivelyWho this might be right forInfluenza ImmunizationHealthy Volunteers Sanofi Pasteur, a Sanofi Company 90